The difference between the Indian version of seputinib/serpatinib and the original drug
Selpercatinib/Selpercatinib(Selpercatinib) The original drug is produced by the original R&D pharmaceutical company, namely Lilai Company; the Indian version of Selpercatinib is produced by India It is produced by pharmaceutical companies. According to the current understanding, there is no relevant pharmaceutical factory in India that produces the original drug or generic drug of Seputinib. However, there are other pharmaceutical companies that produce generic drugs of Seputinib, such as Laos, Bangladesh and other places. The price of the generic drug is cheaper than the original version.
Seputinib is used to treat certain types of non-small cell lung cancer in adults; it is also used to treat certain types of thyroid cancer in adults and children at least 12 years old. When the cancer has spread to other parts of the body (metastatic), patients can be treated with seputinib under the guidance of a doctor. Seputinib can only be used if a patient's cancer has a specific genetic marker (an abnormal "RET" gene). Doctors will test for the presence of this gene. Seputinib may also be used for purposes not listed in this Medication Guide. In clinical studies, some people responded to the drug, but further study is needed.
Up to now, the original research drug is sold in China under the name of Seputinib, but it is not included in medical insurance. The price of each box of 80mg*56 tablets may be more than 10,000 yuan. There are European and American versions of the original drugs sold overseas, with the price of each box ranging from 20,000 to more than 100,000 yuan (prices may fluctuate due to exchange rates). Generic drugs of Seputinib have also been put on the market for sale overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad. For example, the price of 40mg*120 capsules produced by a Laos pharmaceutical factory is more than RMB 4,000 per box (the price may fluctuate due to exchange rates).
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)